Vagus nerve devices are everywhere. The trials tested something slightly different.

Strap a small device to your neck, press a button for two minutes, and your nervous system is supposed to shift out of fight-or-flight. That is the promise behind a category the wellness industry has started calling neurowellness, and vagus nerve stimulators are its flagship product.

The underlying science is not nonsense. That is what makes this one worth doing carefully, because the gap between the research and the thing being sold to you is wider than the marketing suggests, and it is wide in three specific places.

What the research actually shows

A systematic review and meta-analysis published in Psychology, Health & Medicine in 2026 pooled 14 randomised controlled trials of transcutaneous auricular vagus nerve stimulation, meta-analysing 11 of them, in patients with sleep disorders.

The results were positive and moderate. Sleep quality improved with a standardised mean difference of -0.57. Time to fall asleep improved by -0.44. Depression scores moved -0.67 and anxiety scores -0.53. Side effects were mild, and mostly resolved on their own.

Those are real numbers from randomised trials, which is more than most wellness gadgets can point to. The authors' own conclusion is worth quoting rather than paraphrasing, because it is more cautious than any advertisement you will see.

> Given the heterogeneity across studies and the limited clinical interpretability of standardised effect sizes, these findings should be considered preliminary and require confirmation in larger, well-designed RCTs.

Gap one: the ear is not the neck

Almost all of that trial evidence is for stimulation of the ear. The vagus nerve has a branch that surfaces in the outer ear, which is why research devices clip there. The technique even has its own name in the literature: transcutaneous auricular vagus nerve stimulation, taVNS.

The two best-known consumer devices, Pulsetto and Truvaga, go on the neck. That is a different branch, a different depth of tissue and a different stimulation problem. It may work. It is not what those 14 trials tested.

Gap two: patients are not you

The trials recruited people with diagnosed sleep disorders. An effect in a population with a problem does not transfer cleanly to a healthy person buying a gadget because work is stressful. This is the same trap as exercise research showing large effects on depression in people with depression, which does not tell you much about a well person's mood.

Gap three: none of them is cleared to treat anything

Neither Pulsetto nor Truvaga is an FDA-cleared medical device for treating a diagnosed condition. They are sold as wellness wearables for general relaxation, which is a category with a far lower evidence bar.

There is one genuinely interesting wrinkle here that most coverage skips. Truvaga uses the same stimulation parameters as gammaCore, a prescription device from the same company that is FDA-cleared for certain headache conditions. So the hardware lineage is real, even though the consumer product carries no clearance of its own.

And Apollo Neuro, which gets listed alongside these two constantly, is not a vagus nerve stimulator at all. It delivers patterned vibration through a wrist or ankle band. Whatever it does, it is not doing the thing the taVNS trials tested.

What they cost

Pulsetto sells a Lite at 278 dollars and a Fit at 296 dollars. Truvaga sells the 350 at 325 dollars, which delivers 350 two-minute sessions before it is thrown away, and the rechargeable Plus at 499 dollars. Apollo lists a bundle at 448 dollars with an annual subscription attached.

That is a category where the cheapest serious option costs more than a year of most gym memberships, for a device whose evidence base was generated with different hardware on a different part of the body in a different population.

Our take

This is not a scam, and we are not going to pretend it is. Transcutaneous vagus nerve stimulation has 14 randomised trials behind it with moderate, consistent effects on sleep and anxiety, and a good safety record. That puts it well ahead of most of the wellness shelf.

But the trials tested ear stimulation in diagnosed patients, and the products are neck devices sold to healthy people, uncleared, at 278 to 499 dollars. The meta-analysis authors themselves call their own findings preliminary. When the people who ran the numbers are more cautious than the people selling the hardware, that tells you where you are.

If your sleep is the actual problem, the treatment with the strongest evidence is still cognitive behavioural therapy for insomnia, which we covered when we looked at whether neurotech sleep headbands work. It costs nothing to start and it is not a gadget.

If you want to try one anyway, buy from somewhere with a return window, and judge it on whether you sleep better, not on the score in the app.